Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | OTUD3 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | SLC6A19 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | SPECC1L-ADORA2A | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | FCGR2A | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | NDUFB7 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
mRNA | FGF2 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | ARHGAP40 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | DST | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | PHF11 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | CRIM1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |